The 141st Annual Meeting of the Pharmaceutical Society of Japan (Hiroshima)

Presentation information

Oral Presentation

(E) Biopharmaceutics

[29V10-am] がん治療DDS①

Mon. Mar 29, 2021 9:00 AM - 10:24 AM [Room V10] Oral Presentation 10 (Online)

座長:根岸 洋一(東京薬大)、小俣 大樹(帝京大薬)

9:48 AM - 10:00 AM

[29V10-am05S] Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35

○Ryosuke Ono1, Kosuke Takayama1, Fuminori Sakurai1, Hiroyuki Mizuguchi1,2,3,4 (1. Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 2. Global Center for Medical Engineering and Informatics, Osaka University, Osaka, Japan, 3. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, 4. Laboratory of Hepatocyte Regulation, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password